Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Fact: False
Int J Mol Sci 2020, 21(4)
FDA Adverse Event Reporting System (FAERS) data may include reports of musculoskeletal symptoms in patients using GLP-1 receptor agonists, though these reports do not establish causation and may reflect coincidental timing rather than a true drug effect
During Dose Escalation As retatrutide dosing gradually increases, some people may notice common retatrutide side effects such as nausea, constipation, diarrhoea or reduced appetite
US$ 24.12
US$ 25.30
US$ 26.08
US$ 27.21
US$ 23.10
